Fujifilm says medicine research for COVID-19 may last until July
– FILE PHOTO: Avigan Tablets (generic name: Favipiravir), an anti-influenza medicine developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. in Tokyo, Japan, on October 22, 2014. REUTERS / Issei Kato — TOKYO, Jun 7 (Reuters) – Fujifilm Holdings Corp’s investigation into Avigan as a potential treatment for COVID-19 may last … Read more